COVID-19 Live
Total confirmed: 0 Deaths: 0 Recovered: 0 Active: 0 Last updated: January 18, 2022 - 8:27 am (+00:00)
Total confirmed: 0 Deaths: 0 Recovered: 0 Active: 0 Last updated: January 18, 2022 - 8:27 am (+00:00)



The Abbott makes new COVID-19 test technology that looks to be the fastest way of producing results within few minutes, and that can do so on the spot right at point-of-care, without requiring a round trip to a lab. This test for the novel coronavirus causing the current global pandemic has received emergency clearance for use by the U.S. FDA, and will begin production next week, with output of 50,000 per day possible starting next week.

The new Abbott ID NOW COVID-19 test uses the Abbott ID NOW diagnostics platform, which is essentially a lab-in-a-box that is very small in the size that can produce either a positive result in just five minutes or a negative one in under 15 mean that it could be a very useful means to extend coronavirus testing beyond its current availability to more places including clinics and doctor’s offices, and cut down on wait times both in terms of getting tested and receiving a diagnosis.

Unlike the rapid tests that have been used in other countries, and that received a new type of authorization under an FDA guideline that doesn’t confirm the accuracy of the results, this rapid testing solution uses the molecular testing method, which works with saliva and mucus samples swabbed from a patient. This means that it works by identifying a portion of the virus’s RNA in a patient, which means it’s much better at detecting the actual presence of the virus during infection, whereas other tests that search the blood for antibodies that are used in point-of-care settings can only detect antibodies, which might be present in recovered patients who don’t actively have the virus.

In total, Abbott now says that it believes it will produce 5 million tests in April, split between these new rapid tests and the lab tests that it received emergency use authorization for by the FDA on March 18.

With shortages of N95 face due to COVID-19, masks persisting nationwide, healthcare services are scrambling to seek out methods to clean and deal with the reuse of masks protect medical doctors and nurses from COVID-19.

Duke University thinks it has discovered a solution utilizing vaporized hydrogen peroxide to decontaminate the masks.

The course of makes use of specialized gear to vaporize hydrogen peroxide, which might then infuse all of the layers of the masks to kill germs with out degrading masks materials.

The university mentioned it has confirmed efficient and can start utilizing the technology in any respect three of its hospitals, in response to Matthew Stiegel, the director of the Occupational and Environmental Safety Office at Duke.

Ideally, the hospitals would be capable of use fresh masks and never have to attempt to decontaminate their masks, however these usually are not preferred times.

Duke’s determination to make use of hydrogen peroxide to decontaminate N95 masks is based on research performed in 2016, however the apply wasn’t widespread, as a result of the country wasn’t dealing with shortages of masks. Those earlier research additionally didn’t include fit-testing or the resizing of masks for particular person wearers after cleaning. Duke has now carried out that efficacy testing in the real world, the university stated.

“The ability to reuse the crucial N95 masks will boost the hospitals’ ability to protect front-line healthcare workers during this time of critical shortages of N95 masks,” the Cameron Wolfe, MD, associate professor of drugs and infectious disease specialist mentioned.

“We could stand up in front of our healthcare staff and state with confidence that we are using a proven decontamination method,” Brown mentioned. “It has been a proven method for years. While this alone will not solve the problem, if we and others can reuse masks even once or twice, that would be a huge benefit given the current shortages of masks.”